Celyad's R&D day 2019

Members of the Celyad leadership team will provide an overview of the recent breakthroughs in the R&D pipeline, updates on key clinical trials and the Company's cell therapy manufacturing capabilities. In addition, Celyad will unveil its next-generation NKG2D preclinical program CYAD-02 as well as the Company’s proprietary non-gene edited allogeneic platforms including the CYAD-200 series of shRNA-based CAR-T programs.

Webcast Information

The full program will be webcast live and can be accessed here.

Click here to download the slide deck presentation

Click here to watch the webcast 

Cowen 39th Annual Health Care Conference

Date: Monday, March 11, 2019

Presentation Time: 3:30 p.m. ET

Location: Boston, MA

A live webcast of the presentation can be accessed here

8th Annual SVB Leerink Global Healthcare Conference

Date: Thursday, February 28, 2019

Presentation time: 1:30 p.m. ET

Location: New York, NY

Download the MP3 file from the 8th Annual SVB Leerink Global Conference here

37th Annual JP Morgan Healthcare Conference

Celyad Presentation on January 7 - 10, 2019

Click here to download the presentation

ASH 2018 - Analyst/Investor Event

Celyad ASH review on Monday, December 3, 2018, beginning from 8 to 10 PM (PT) to review data presented at ASH.

The event will be webcast live and can be accessed here

The 30th Annual Piper Jaffray Healthcare Conference

Celyad Presentation on November 27, 2018 at 11:30 AM (EST)

 

Click here to access the webcast 

SITC 2018 Presentation

Click here to download the presentation from SITC 2018

Leerink Partners Roundtable Series: Rare Disease & Oncology

Celyad Presentation on October 3rd, 2018 at 4:00 PM (ET)

Click here to access the webcast 

Celyad's 10th anniversary presentation

Click here to download the presentation from Celyad 10th anniversary

First Half 2018 Conference Call

Click here to listen to the conference call

Participation to VFB-Happening

Christian Homsy will present Celyad during the VFB-Happening. For more information click here 

Latest News

Celyad to Participate at Upcoming Healthcare Conferences

Celyad to Participate at Upcoming Healthcare Conferences

Celyad Reports First Half 2018 Financial Results and Operational Progress

Celyad Reports First Half 2018 Financial Results and Operational Progress

Celyad to Host Key Opinion Leader Meeting on CAR-T Therapy for the Treatment of Blood Cancers

Celyad to Host Key Opinion Leader Meeting on CAR-T Therapy for the Treatment of Blood Cancers

Discover all news

Analyst coverage

Want to see more?

Analyst coverage